| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Ryan Serdenes, Samuel Orr, Pamela Trio, Seetha Chandrasekhara, Meghan Musselma. A Rare Case Report of a Corpus Callosal Splenial Lesion in the Context of Atypical Neuroleptic Malignant Syndrome. Journal of investigative medicine high impact case reports. vol 9. 2021-10-15. PMID:34229456. |
in this report, we describe a case of atypical neuroleptic malignant syndrome (nms) presenting with an isolated lesion in the splenium of the corpus callosum (ilscc). |
2021-10-15 |
2023-08-13 |
Not clear |
| Lara Youniss, Michele Thomas, Erica A K Davi. Probable haloperidol decanoate-induced fever in an African American with benign ethnic neutropenia: A case report. The mental health clinician. vol 11. issue 5. 2021-10-09. PMID:34621607. |
we present a case in which a patient developed fever and leukocytosis subsequent to each monthly haloperidol decanoate injection, an adverse reaction that does not meet the diagnostic criteria of neuroleptic malignant syndrome (nms) or any previously reported adverse reaction for this medication. |
2021-10-09 |
2023-08-13 |
Not clear |
| Johana Patricia Mogollon Díaz, Linda Yurani Lizcano Toloza, Angie Yarlady Serrano García, Camilo Andrés Alquichire Luna, Diego Fernando García Bohorquez, María Fernanda Chaparro Durán, María Valentina Cáceres Valer. Neuroleptic Malignant Syndrome Associated with Atypical Antipsychotics: A Case Report. Revista Colombiana de psiquiatria (English ed.). 2021-10-07. PMID:34243899. |
neuroleptic malignant syndrome (nms) is uncommon, with an incidence of 0.01% to 3.23%, and is associated with the use of drugs that intervene with dopamine, causing hyperthermia, muscular rigidity, confusion, autonomic instability and death. |
2021-10-07 |
2023-08-13 |
Not clear |
| Daniel Guinart, Fuminari Misawa, Jose M Rubio, Justin Pereira, Renato de Filippis, Chiara Gastaldon, John M Kane, Christoph U Correl. A systematic review and pooled, patient-level analysis of predictors of mortality in neuroleptic malignant syndrome. Acta psychiatrica Scandinavica. vol 144. issue 4. 2021-09-22. PMID:34358327. |
neuroleptic malignant syndrome (nms) is a potentially fatal, idiosyncratic reaction to antipsychotics. |
2021-09-22 |
2023-08-13 |
Not clear |
| Rhea El Khoury, Anthony Kassab, Ramez Dagher, Herve Javelot, Rabih El Chammay, Sami Rich. Reconsidering Rigidity in the Diagnosis of Neuroleptic Malignant Syndrome: A Case Report. Journal of psychiatric practice. vol 26. issue 4. 2021-09-01. PMID:32692129. |
neuroleptic malignant syndrome (nms) is a rare but potentially fatal syndrome classically encountered in patients receiving typical antipsychotic agents. |
2021-09-01 |
2023-08-13 |
Not clear |
| Anna Eveline Röell, Dharmanand Ramnarain, Rama Kama. Successful Treatment of Severe Gamma-Hydroxybutyric Acid Withdrawal Syndrome With Dantrolene. Cureus. vol 13. issue 7. 2021-08-20. PMID:34408951. |
as the patient developed hyperthermia and rhabdomyolysis, signs of a neuroleptic malignant syndrome (nms), he was treated with dantrolene. |
2021-08-20 |
2023-08-13 |
Not clear |
| L Kuhlwilm, C Schönfeldt-Lecuona, M Gahr, B J Connemann, F Keller, A Sartoriu. The neuroleptic malignant syndrome-a systematic case series analysis focusing on therapy regimes and outcome. Acta psychiatrica Scandinavica. vol 142. issue 3. 2021-08-18. PMID:32659853. |
neuroleptic malignant syndrome (nms) is a rare, potentially life-threatening antipsychotic-associated disorder that requires an efficient and timely therapy. |
2021-08-18 |
2023-08-13 |
Not clear |
| Sanjay Prakash, Deepali Lodha, Kalu Singh Rawa. Coexistence of serotonin syndrome and neuroleptic malignant syndrome: does it exist? BMJ case reports. vol 14. issue 8. 2021-08-18. PMID:34400419. |
we considered the presence of both ss and neuroleptic malignant syndrome (nms) in this case. |
2021-08-18 |
2023-08-13 |
Not clear |
| Esther Shan Lin Hor, Gurpreet Pal Singh, Nurul Akhmar Omar, Vincent Russel. Atypical neuroleptic malignant syndrome and non-alcoholic Wernicke's encephalopathy. BMJ case reports. vol 14. issue 8. 2021-08-09. PMID:34353834. |
laboratory tests revealed elevated creatine kinase, acute kidney injury with metabolic acidosis and transaminitis, leading to a provisional diagnosis of neuroleptic malignant syndrome (nms). |
2021-08-09 |
2023-08-13 |
Not clear |
| C Nestor, D O'Brien, R Dwye. Neuroleptic Malignant Syndrome Secondary to Quetiapine in Critical Care: A Case Report. A&A practice. vol 14. issue 11. 2021-07-28. PMID:32985851. |
we report a case of an elderly patient who developed clinical and biochemical evidence of neuroleptic malignant syndrome (nms) 5 days after quetiapine was commenced. |
2021-07-28 |
2023-08-13 |
Not clear |
| Saral Desai, Tinu Hirachan, Anca Toma, Adela Gerolemo. Malignant Catatonia Versus Neuroleptic Malignant Syndrome. Cureus. vol 13. issue 6. 2021-07-27. PMID:34306883. |
the clinical presentations of neuroleptic malignant syndrome (nms) and malignant catatonia (mc) are similar, posing a diagnostic challenge. |
2021-07-27 |
2023-08-13 |
Not clear |
| Fuminari Misawa, Yasuyuki Okumura, Yoshinori Takeuchi, Yasuo Fujii, Hiroyoshi Takeuch. Neuroleptic malignant syndrome associated with long-acting injectable versus oral second-generation antipsychotics: Analyses based on a spontaneous reporting system database in Japan. Schizophrenia research. vol 231. 2021-07-05. PMID:33752105. |
one reason is the concern that lai-aps might cause serious adverse events such as neuroleptic malignant syndrome (nms) and lead to prolonged symptoms compared with oral treatment. |
2021-07-05 |
2023-08-13 |
Not clear |
| Pasquale Brogna, Rosangela Colasuonno, Flavia Di Michele, Angela Maria Paterniti, Alessandra Talamo, Michele Ribolsi, Tommaso B Jannini, Alberto Siracusano, Cinzia Niol. Diagnostic and therapeutic challenges in neuroleptic malignant syndrome: a severe medical case. Rivista di psichiatria. vol 55. issue 4. 2021-06-24. PMID:32724236. |
neuroleptic malignant syndrome (nms) is a rare, idiosyncratic medical emergency usually associated with the use of dopamine antagonists, commonly typical antipsychotic drugs. |
2021-06-24 |
2023-08-13 |
Not clear |
| Anish Shouan, Ankit Kumar Sinha, Sandeep Grove. Neuroleptic malignant syndrome associated with the use of injection zuclopenthixol acetate. Industrial psychiatry journal. vol 29. issue 2. 2021-06-24. PMID:34158726. |
there are very few reports of neuroleptic malignant syndrome (nms) with use of zuclopenthixol monotherapy. |
2021-06-24 |
2023-08-13 |
Not clear |
| Kazuhito Nomura, Sonoko Sakawaki, Eiji Sakawaki, Ayumu Yamaoka, Wakiko Aisaka, Hiroyuki Okamoto, Yoshihiro Takeyama, Shuji Uemura, Eichi Narimats. Successful diagnosis and treatment of pulmonary aspergillosis-related malignant catatonia using propofol and quetiapine: A case report. Medicine. vol 100. issue 19. 2021-06-22. PMID:34106671. |
its clinical symptoms are similar to those of another disorder, neuroleptic malignant syndrome (nms), and it is often difficult to distinguish between the 2 disorders. |
2021-06-22 |
2023-08-13 |
Not clear |
| Daniel Guinart, Fuminari Misawa, Jose M Rubio, Justin Pereira, Harshit Sharma, Georgios Schoretsanitis, John M Kane, Christoph U Correl. Outcomes of Neuroleptic Malignant Syndrome With Depot Versus Oral Antipsychotics: A Systematic Review and Pooled, Patient-Level Analysis of 662 Case Reports. The Journal of clinical psychiatry. vol 82. issue 1. 2021-06-11. PMID:33238083. |
this systematic review and pooled, patient-level analysis of neuroleptic malignant syndrome (nms) case reports and series compared nms characteristics and outcomes during long-acting injectable antipsychotic (lai) versus oral antipsychotic (oap) treatment. |
2021-06-11 |
2023-08-13 |
Not clear |
| Oona Nørgaard van Achter, Selvavathany Sivagurunatha. [Neuroleptic malignant syndrome treated with electroconvulsive therapy]. Ugeskrift for laeger. vol 182. issue 48. 2021-06-11. PMID:33269687. |
neuroleptic malignant syndrome (nms) is a rare but severe complication to antipsychotic treatment. |
2021-06-11 |
2023-08-13 |
Not clear |
| Yub Raj Sedhai, Alok Atreya, Prabin Phuyal, Soney Basnyat, Sagar Pokhre. Case Report: Ziprasidone induced neuroleptic malignant syndrome. F1000Research. vol 10. 2021-06-02. PMID:33763203. |
neuroleptic malignant syndrome (nms) is a well-recognized neurologic emergency. it presents with classic features including hyperthermia, autonomic instability, muscle hypertonia, and mental status changes. the syndrome is potentially fatal and is associated with significant morbidity due to complications such as rhabdomyolysis, acute kidney injury, and ventricular arrhythmias due to the trans-cellular electrolyte shift. nms is conventionally associated with the first-generation antipsychotic agents, however, has been described with the use of atypical and novel antipsychotics including ziprasidone. a case of nms with ziprasidone use at the therapeutic dose is reported here. |
2021-06-02 |
2023-08-13 |
Not clear |
| Christie Sun, Hannah Sweet, Alicia B Minns, Desiree Shapiro, Willough Jenkin. A Mixed Presentation of Serotonin Syndrome vs Neuroleptic Malignant Syndrome in a 12-Year-Old Boy. Pediatric emergency care. vol 36. issue 10. 2021-05-28. PMID:29698346. |
neuroleptic malignant syndrome (nms) and serotonin syndrome (ss) are serious medical conditions associated with commonly prescribed psychiatric medications. |
2021-05-28 |
2023-08-13 |
Not clear |
| Deborah León-Amenero, Jeff Huarcaya-Victori. Neuroleptic Malignant Syndrome in Children and Adolescents: Systematic Review of Case Reports. Revista Colombiana de psiquiatria (English ed.). 2021-05-25. PMID:33735054. |
neuroleptic malignant syndrome (nms) is a rare and potentially fatal drug adverse reaction. |
2021-05-25 |
2023-08-13 |
Not clear |